Search Results - "Wei, Lisa L"
-
1
Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery
Published in Molecular therapy (05-09-2018)“…This study evaluated the safety and tolerability of ocular RS1 adeno-associated virus (AAV8-RS1) gene augmentation therapy to the retina of participants with…”
Get full text
Journal Article -
2
Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications
Published in PloS one (18-09-2014)“…To evaluate localization and transgene expression from adenoviral vector of serotypes 5, 35, and 28, ± an RGD motif in the fiber following intravitreal or…”
Get full text
Journal Article -
3
“Para-retinal” Vector Administration into the Deep Vitreous Enhances Retinal Transgene Expression
Published in Molecular therapy. Methods & clinical development (11-09-2020)“…Intravitreal administration for human adeno-associated vector (AAV) delivery is easier and less traumatic to ocular tissues than subretinal injection, but it…”
Get full text
Journal Article -
4
Ocular and systemic safety of a recombinant AAV8 vector for X-linked retinoschisis gene therapy: GLP studies in rabbits and Rs1-KO mice
Published in Molecular therapy. Methods & clinical development (01-01-2016)“…X-linked retinoschisis (XLRS) is a retinal disease caused by mutations in the gene encoding the protein retinoschisin (RS1) and is one of the most common…”
Get full text
Journal Article -
5
Retinal Neuroprotection against Ischemic Injury Mediated by Intraocular Gene Transfer of Pigment Epithelium-Derived Factor
Published in Investigative ophthalmology & visual science (01-10-2003)“…To determine whether intraocular gene transfer of pigment epithelium-derived factor (PEDF) protects the retina from ischemia-reperfusion injury. Four days…”
Get full text
Journal Article -
6
Intraocular gene transfer of pigment epithelium-derived factor rescues photoreceptors from light-induced cell death
Published in Journal of cellular physiology (01-02-2005)“…In this study, we investigated whether intraocular gene transfer of pigment epithelium‐derived factor (PEDF) ameliorates the extent of light‐induced…”
Get full text
Journal Article -
7
Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial
Published in Molecular therapy (02-06-2021)“…This study explored systemic immune changes in 11 subjects with X-linked retinoschisis (XLRS) in a phase I/IIa adeno-associated virus 8 (AAV8)-RS1 gene therapy…”
Get full text
Journal Article -
8
CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function
Published in Investigative ophthalmology & visual science (01-10-2014)“…Ciliary neurotrophic factor (CNTF) protects rod photoreceptors from retinal degenerative disease in multiple nonhuman models. Thus far, CNTF has failed to…”
Get full text
Journal Article -
9
Intravitreal Ciliary Neurotrophic Factor Transiently Improves Cone-Mediated Function in a CNGB3-/- Mouse Model of Achromatopsia
Published in Investigative ophthalmology & visual science (01-10-2015)“…Ciliary neurotrophic factor (CNTF) was recently shown to augment cone function in CNGB3 mutant achromat dogs. However, testing CNTF-releasing implant in human…”
Get full text
Journal Article -
10
Convergence of Human Genetics and Animal Studies: Gene Therapy for X-Linked Retinoschisis
Published in Cold Spring Harbor perspectives in medicine (01-08-2015)“…Retinoschisis is an X-linked recessive genetic disease that leads to vision loss in males. X-linked retinoschisis (XLRS) typically affects young males;…”
Get full text
Journal Article -
11
Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial
Published in Human gene therapy (01-02-2006)“…Twenty-eight patients with advanced neovascular age-related macular degeneration (AMD) were given a single intravitreous injection of an E1-, partial E3-,…”
Get more information
Journal Article -
12
Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization
Published in Journal of cellular physiology (01-08-2001)“…In this study, we investigated whether overexpression of pigment epithelium‐derived factor (PEDF) by gene transfer can inhibit neovascularization by testing…”
Get full text
Journal Article -
13
Preclinical safety evaluation of a recombinant AAV8 vector for X-linked retinoschisis after intravitreal administration in rabbits
Published in Human gene therapy. Clinical development (01-12-2014)“…X-linked retinoschisis (XLRS) is a retinal disease caused by mutations in the gene encoding the protein retinoschisin (RS1) and one of the most common causes…”
Get more information
Journal Article -
14
Alternate serotype adenovector provides long-term therapeutic gene expression in the eye
Published in Molecular vision (30-12-2008)“…To determine whether the duration of transgene expression from an alternate adenovector serotype, Ad35, can provide advantages over an Ad5 serotype vector…”
Get full text
Journal Article -
15
Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells
Published in Cancer research (Chicago, Ill.) (01-07-2001)“…KAI1 is a metastasis suppressor gene for human prostate cancer and is also involved in the progression of a variety of other human cancers. Previously, we have…”
Get full text
Journal Article -
16
Repeat Administration of Proteins to the Eye With a Single Intraocular Injection of an Adenovirus Vector
Published in Molecular therapy (01-08-2008)“…Delivery of therapeutic proteins, such as antiangiogenic proteins, to the eye is a demonstrated method for the control of age-related macular degeneration…”
Get full text
Journal Article -
17
The role of lacrimal intubation in the management of facial trauma and tumor resection
Published in Plastic and reconstructive surgery (1963) (01-06-2005)“…Lacrimal drainage dysfunction is a common and problematic consequence of any pathologic process that interferes with the physiology or continuity of the…”
Get full text
Journal Article -
18
Trans-scleral delivery of antiangiogenic proteins
Published in Journal of ocular pharmacology and therapeutics (01-02-2008)“…In this study, we investigated the penetration of various proteins into the mouse eye after a periocular injection of the protein or an adenoviral vector (Ad)…”
Get more information
Journal Article -
19
Persistent Expression of PEDF in the Eye Using High-capacity Adenovectors
Published in Molecular therapy (01-12-2008)“…Ocular neovascularization, the growth of abnormal blood vessels in the eye, is a factor shared by the most common blinding diseases in developed countries…”
Get full text
Journal Article -
20
Repeated Administration of Adenovector in the Eye Results in Efficient Gene Delivery
Published in Investigative ophthalmology & visual science (01-01-2006)“…To determine whether repeat administration of an adenovector (Ad) into the eye results in efficient gene delivery and to test whether transgenes can be…”
Get full text
Journal Article